Clostridium difficile colitis: an efficient clinical approach to diagnosis

Area of Science:

• Infectious Diseases
• Gastroenterology
• Clinical Microbiology

Background:

• Clostridium difficile colitis is a significant healthcare-associated infection.
• Accurate and timely diagnosis is crucial for effective patient management and infection control.
• Identifying predictive factors can aid in clinical decision-making for diagnostic testing.

Purpose of the Study:

• To identify clinical and laboratory variables indicative of Clostridium difficile colitis.
• To determine the optimal number of stool specimens required to exclude the diagnosis.

Main Methods:

• Prospective study involving 268 inpatients with stool specimens tested for C. difficile toxin.
• Utilized enzyme-linked immunoassay (EIA) and tissue-culture assay for toxin detection.
• Assessed clinical data, antibiotic history, hospital stay duration, and fecal leukocyte presence.

Main Results:

• 43 of 268 inpatients tested positive for C. difficile toxin.
• Predictive factors included delayed antibiotic onset, prolonged hospital stay, fecal leukocytes, semiformed stools, and cephalosporin use.
• 79% of positive cases were identified with the first stool specimen; 91% with the second, yielding a 97% negative predictive value for the first sample.

Conclusions:

• Clinical and laboratory data can effectively guide the decision to test for C. difficile toxin.
• These factors also assist in determining when the diagnosis can be reasonably excluded.
• The findings support a targeted approach to C. difficile testing, optimizing resource utilization.